This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Cadila Healthcare Limited. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Vikas Patel: Innovator in Pharmaceutical Chemistry
Introduction
Vikas Patel is a prominent inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with hypolipidemic and hypocholesteremic activities. With a total of three patents to his name, Patel's work is recognized for its potential impact on health and medicine.
Latest Patents
Patel's latest patents include a process for the preparation of pyrroles having hypolipidemic hypocholesteremic activities. This invention provides pyrroles that exhibit beneficial effects on lipid levels in the body. Additionally, he has developed a process for the preparation of saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs, or intermediates. Another notable patent focuses on an improved process for the preparation of pyrrole derivatives, specifically 2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoate and its related compounds.
Career Highlights
Vikas Patel is currently associated with Cadila Healthcare Limited, a leading pharmaceutical company in India. His work at Cadila Healthcare has allowed him to explore innovative solutions in drug development and formulation. Patel's expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Patel has collaborated with notable colleagues, including Ramesh Chandra Singh and Jagdish Maganlal Patel. These collaborations have fostered a productive environment for research and innovation in pharmaceutical sciences.
Conclusion
Vikas Patel's contributions to pharmaceutical chemistry through his patents and work at Cadila Healthcare Limited highlight his commitment to advancing health solutions. His innovative approaches in developing hypolipidemic and hypocholesteremic compounds demonstrate the potential for significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
